JPRN-UMIN000040346已完成未知
FACTOR Xa INHIBITORS FOR VENOUS THROMBOEMBOLISM MANAGEMENT IN PATIENT WITH CANCER - FACTOR Xa INHIBITORS FOR VTE MANAGEMENT IN CANCER: A META-ANALYSIS
Dr. Soetomo General Hospital0 个研究点目标入组 2,000 人开始时间: 2020年6月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •All phase II trials, trials involving anti-platelet in control arm of treatment, trials using anticoagulant as post-procedure prophylaxis of VTE
研究者
相似试验
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonists.Atrial fibrillation catheter ablationMedDRA version: 19.1Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10071667Term: Persistent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10066582Term: Recurrent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-002442-45-ATKompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonist.EUCTR2014-002442-45-DEKompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonists.Atrial fibrillation catheter ablationMedDRA version: 18.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 18.0Level: LLTClassification code 10071667Term: Persistent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 18.0Level: LLTClassification code 10066582Term: Recurrent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 18.0Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-002442-45-ESThe Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AFNET e.V.)]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonist.EUCTR2014-002442-45-BEThe Kompetenznetz Vorhofflimmern e.V. [German Atrial Fibrillation Competence Network association (AFNET e.V.)]650
进行中（未招募）
1 期
During atrial fibrillation catheter ablation procedure treatment with anticoagulant drugs is necessary in order to prevent blood clotting and thereby decrease the risk of procedure related strokes. In this study two different types of anticoagulant drugs are being compared during and after the atrial fibrillation catheter ablation procedure: the novel direct factor Xa inhibitor apixaban and any of the standard vitamin K antagonists.Atrial fibrillation catheter ablationMedDRA version: 19.1Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10071667Term: Persistent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10003661Term: Atrial fibrillation paroxysmalSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 19.1Level: LLTClassification code 10066582Term: Recurrent atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2014-002442-45-DKKompetenznetz Vorhofflimmern e.V. [Atrial Fibrillation NETwork (AFNET)]650